Evidence map›Paper›PMID 40342532›Full record

ArticleBiochemistry and biophysics reports2025

High-resolution transcriptome analysis on a mouse model of neonatal hypoxic-ischemic encephalopathy using single-nucleus RNA-seq.

Nao Wakui, Takashi Shimbo, Morifumi Hanawa, Tomomi Kitayama, Yukari Yamamoto, Yuya Ouchi, Kotaro Saga, Aiko Okada, Kazuya Mimura, Katsuto Tamai and 1 more

Abstract read
In one paragraph

Article in Biochemistry and biophysics reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Nao WakuiDepartment of Obstetrics and Gynecology, Graduate School of Medicine, Osaka University, Suita, Japan.
Takashi ShimboDepartment of Stem Cell Therapy Science, Graduate School of Medicine, Osaka University, Suita, Japan.
Morifumi HanawaStemRIM Inc., Ibaraki, Osaka, Japan.
Tomomi KitayamaStemRIM Institute of Regeneration-Inducing Medicine, Osaka University, Suita, Osaka, Japan.
Yukari YamamotoStemRIM Institute of Regeneration-Inducing Medicine, Osaka University, Suita, Osaka, Japan.
Yuya OuchiStemRIM Institute of Regeneration-Inducing Medicine, Osaka University, Suita, Osaka, Japan.
Kotaro SagaDepartment of Stem Cell Therapy Science, Graduate School of Medicine, Osaka University, Suita, Japan.
Aiko OkadaDepartment of Obstetrics and Gynecology, Graduate School of Medicine, Osaka University, Suita, Japan.
Kazuya MimuraDepartment of Obstetrics and Gynecology, Graduate School of Medicine, Osaka University, Suita, Japan.
Katsuto TamaiDepartment of Stem Cell Therapy Science, Graduate School of Medicine, Osaka University, Suita, Japan.
Masayuki EndoDepartment of Obstetrics and Gynecology, Graduate School of Medicine, Osaka University, Suita, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neonatal hypoxic-ischemic encephalopathy (HIE) encompasses brain injuries resulting from dysregulated oxygen or blood flow to the brain before, during, or immediately after birth. During the acute phase, neuronal damage is driven by excitotoxicity, with permanent injury manifesting over the subsequent hours. Treatment options have limited efficacy, requiring deeper insights into HIE pathogenesis. Recent advances in single-cell RNA sequencing have enabled molecular investigations of diverse diseases. However, the large size of certain cells, such as neurons, has posed challenges in studying conditions where neuronal damage is central. Thus, we employed single-nucleus RNA sequencing to evaluate damages in a mouse model of HIE and found pronounced changes in the hippocampus with significantly reduced neuronal populations. We observed the characteristic activation of hippocampal microglia, confirmed by immunostaining in the HIE model. These alterations were specific to combined hypoxic-ischemic conditions and were not observed with hypoxia or ischemia alone. These findings provide insights into the molecular and anatomical impact of HIE and highlight the hippocampus as a critical focus for understanding disease mechanisms and therapeutic development.

Indexed as

HippocampusInterferon activationMouse modelNeonatal hypoxic-ischemic encephalopathyNeuronal damageSingle-nucleus RNA sequencing

Identifiers

PMID40342532
PMCPMC12059396

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.